Evicenter
P&T meetings

Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer
Hansa Biopharma
Regulatory submission
BLA submitted December 2025
Last updated
85 sources

Executive summary

Burden of Kidney transplantation in highly sensitized patients

1 evidence topic · 5 sources

Summary

Sensitization can follow pregnancy, blood transfusion, tissue grafting, or previous transplantation. Highly sensitized candidates are reported to comprise approximately 10–15% of transplant waiting lists across the United States and Europe. A United States allocation analysis found that candidates with CPRA of at least 99.9% continued to have lower transplant rates than the overall average despite national priority. Kidney failure affects daily activities, and in-center hemodialysis commonly requires three sessions per week, each lasting approximately four hours.